Loncar Funds has a clear mission to invest in a group of companies that aim to treat cancer. Its only ETF offering attempts to track the performance of companies that develop drugs aimed at curing cancer by utilizing the body’s own immune system.
Loncar Funds Quick Facts
- Headquarters: ,
- U.S. Listed ETFs: 1
- Expense Ratio Range: 0.79% – 0.79%
- Avg. Expense Ratio: 0.79%
- Loncar Funds maintains ETFs in the following ETFdb Categories: Health & Biotech Equities
As of 01/13/2017